The Syneos Health Podcast

What are the signals today that will define the future of oncology treatment tomorrow? The Syneos Health Podcast: Early Signals brings together leaders across biopharma, healthcare, academia and technology to explore the innovations reshaping drug development in oncology. Hosted by experts across Syneos Health, including Wael Harb, MD, Head of Research and Development and Scientific Strategy in on...

In this episode of the Site Realities series, Tammy D’Lugin-Monroe continues her conversation with Przemyslaw Wziatek , Country Head for Poland and Ukraine within Clinical Operations at Syneos Health, exploring how sites navigate the complexity of working within large CRO organizations.  Together, they discuss the importance of clear communication pathways, operational ownership and timely escalat...

In this episode of the Site Realities series, Tammy D’Lugin-Monroe sits down with Przemyslaw Wziatek , Country Head for Poland and Ukraine within Clinical Operations at Syneos Health, to explore how relationships between Clinical Research Associates (CRAs) and Clinical Sites are evolving in today’s increasingly complex research environment.   As competition for high-performing sites intensifies, s...

Commercialization decisions are shaping success earlier than ever in the product lifecycle, from value and access to launch strategy, deployment and stakeholder engagement. Conversations on Commercialization , a new spinoff of the Syneos Health Podcast, explores what this shift means for biopharma companies and what it takes to compete in a rapidly evolving market.  Led by Tyler Cowan, Commercial...

In this episode of the Syneos Health Podcast: Site Realities series, host Tammy D’Lugin-Monroe and Audra Holleman , Head, Country Operations, Americas at Syneos Health explore the evolving role of the clinical research associate (CRA)—and why it matters more than ever. From shifting expectations around site relationships to the growing impact of technology and AI, the conversation highlights how C...

In this episode of the Syneos Health Podcast: Site Realities series, Tammy D’Lugin-Monroe , Head of Trial Enablement Solutions at Syneos Health, sits down with Mimi Fenton, MPH, PhD , CEO of Cedar Health Research, to explore what it truly means to operate on the front lines of clinical research. Drawing on her experience across pharma, CRO and site leadership, Mimi offers a candid view into the op...

In this episode of The Syneos Health Podcast, Conversations on Commercialization , Tyler Cowan , VP, Commercial speaks with Paul Rittman , President and General Manager of Almirall US, about how payer consolidation and PBM influence are reshaping dermatology commercialization.    They discuss how pharmaceutical companies must adapt launch strategy, market access planning and clinical differentiati...

In this episode, Lynn Hamilton speaks with Stuart Goodall , Senior Vice President at Syneos Health, about how regulatory functions are evolving in response to growing complexity, accelerating timelines and emerging technologies. With more than 35 years of global experience, Stuart offers an unfiltered perspective on what regulatory and medical writing teams need to succeed today—and how to scale s...

In this forward-looking episode, Lynn Hamilton sits down with Bret Couturier , Executive Director, FSP 360 at Syneos Health, to explore how sponsors can shift from incremental improvements to intentional design when it comes to site experience. With a career spanning frontline monitoring to strategic FSP leadership, Bret offers practical insights into what's working, and what’s holding teams...

In this episode of the Functionally Speaking series, host Lynn Hamilton speaks with Carol Aliyar , Executive Vice President and Global Head of Safety and Pharmacovigilance (PV) at Syneos Health, about the transformation of PV from a highly regulated, task-oriented function into a more strategic and technology-enabled discipline. With over 30 years in the industry and a career that spans commercial...

What does it take to run a truly effective Functional Service Provider (FSP) model in today’s biopharma landscape? From harmonizing global teams to embedding innovation into daily delivery, FSP engagement is more than a resourcing solution — it’s about strategic collaboration and approaches that accelerate delivery. The Syneos Health Podcast: Functionally Speaking series explores the nuances that...

What does it take to run a truly effective Functional Service Provider (FSP) model in today’s biopharma landscape? From harmonizing global teams to embedding innovation into daily delivery, FSP engagement is more than a resourcing solution — it’s about strategic collaboration and approaches that accelerate delivery. The Syneos Health Podcast: Functionally Speaking series explores the nuances that...

What does it take to redefine psychiatric care with psychedelic therapies? In this episode, Dr. Dan Karlin of MindMed joins host Dr. Talar Hopyan to discuss the clinical, regulatory and cultural shifts underway in mental health.  They explore the momentum behind MindMed’s LSD program for anxiety and depression, how the team is preparing for NDA filing and commercialization and why purposeful growt...

What’s the path to better measurement in psychiatry?    In this episode, Dr. Alexandria Wise speaks with Dr. Anzar Abbas —neuroscientist, innovator and CNS Summit 2025 Innovation Showcase winner—about how Brooklyn Health is using AI to standardize rater training and improve data quality in psychiatric trials.  They discuss why subjective interviews still dominate, where today’s models fall short a...

What if protein degradation could address neurodegenerative diseases, not just cancer? In this episode, Dr. Angela Cacace , CSO at Arvinas, speaks with Dr. Talar Hopyan, Global Head of CST at Syneos Health, about how the company is advancing a degrader targeting LRRK2 in Parkinson’s disease and why early-stage signals in healthy volunteers are raising new possibilities for CNS care.  They discuss...

Now in its second season, this exclusive CNS Summit podcast series features biopharma leaders sharing bold ideas, breakthrough innovations and what it takes to move smarter and faster for patients.  How is a mid-sized, family-owned company scaling with impact in specialty neurology? Stefan König , CEO of Merz Therapeutics, joins guest host Andy Moniz , VP of Therapeutic Strategy and Innovation at...

A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed.  What if drug naming could be faster, smarter and more aligned to brand strategy?  In this episode, Addison Whitney’s Joe Daley , President, and Bill Purdy , SVP and Managing Director of Global Brand Developm...

Now in its second season, this exclusive CNS Summit podcast series features biopharma leaders sharing bold ideas, breakthrough innovations and what it takes to move smarter and faster for patients.  Compass Pathways CEO Kabir Nath joins host, Dr. Alex Wise , Global Head of Neuroscience at Syneos Health, to discuss the clinical promise of psychedelics and what’s next for psychiatric innovation.   W...

A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed.   In this episode, recorded at Fierce Pharma Week 2025, Tyler Cowan , VP Commercial at Syneos Health, joins Hruta Shah , Senior Engagement Manager for Syneos Health Consulting, to break down the high-stakes r...

A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed.   Recorded at Fierce Pharma Week 2025, the series begins with a two-part conversation with Mark Bard , co-founder of the Digital Health Coalition.  In this episode, Bard joins host Tyler Cowan, VP, Commercial...

A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed.   Recorded at Fierce Pharma Week 2025, the series continues with part two of our conversation with Mark Bard , co-founder of the Digital Health Coalition.  In this episode, Bard and host Tyler Cowan turn the...

Hosted by Drew Beck , Head of Strategy, Growth and Innovation for Syneos Health Learning Solutions, this limited series dives into the breakthrough trends redefining health in 2025 and beyond. From bold moves in R&D and medical affairs to next-gen trial design, product launch strategies and the future of healthcare communications, each episode connects you with the minds driving real change. B...

In this episode, host Sara Rubin is joined by Cheryl Allen, RPh , founding partner at Curatio Advisors, to explore how manufacturers can evolve their access strategies in response to the growing complexity of specialty-like therapies. With a career spanning specialty pharmacy, digital health innovation and commercialization strategy, Cheryl shares how reframing these products as “enhanced retail”...

In this special edition of the Syneos Health Podcast recorded from the floor of Asembia’s AXS25 Summit, host Michael Sarshad sits down with Kim Plesnarski , SVP of Market Access and Patient Support Services at Syneos Health and Kelly Carter , AVP of Patient Support at Amgen, to unpack the evolving landscape of patient support.  The discussion explores the blurring lines between general and special...

In this episode of our Navigating Modern Market Access series, recorded from the floor of Asembia's AXS25 Summit, host Sara Rubin sits down with Rob Truckenmiller , the newly appointed CEO of PharmaCord.  Drawing from his deep experience across small, mid-sized and large pharmaceutical companies, Rob explores how market access strategies must evolve to meet today’s healthcare challenges. From...